Creatinine Quantitative Testing Drug - Vietnam Registration 230000148/PCBB-BYT
Access comprehensive regulatory information for Creatinine Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loแบกi B medical device is registered under number 230000148/PCBB-BYT and manufactured by Ortho-Clinical Diagnostics Inc..
This page provides complete technical specifications, regulatory compliance details, 3 companies making similar products including Abbott Ireland Diagnostics Division, Roche Diagnostics (Suzhou) Ltd., and 4 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
230000148/PCBB-BYT
000.00.04.G18-230222-0014
VITROS Chemistry Products CREA Slides
6802584
Technical Details
Used in in vitro diagnosis to measure the concentration of creatinine (CREA) in serum, plasma, and urine on the VITROS 250/350/5.1 FS/4600/XT 3400 systems and the integrated VITROS 5600/XT 7600 systems.
Dates and Status
Feb 23, 2023
Creatinine Quantitative Testing Drug
Roche Diagnostics (Suzhou) Ltd.
240000442/PCBB-HCM
Creatinine Quantitative Testing Drug
FUJIFILM Wako Pure Chemical Corporation
240000301/PCBB-HN
Creatinine Quantitative Testing Drug
Abbott Ireland Diagnostics Division
230002151/PCBB-HN
Creatinine Quantitative Testing Drug
Abbott Ireland Diagnostics Division
230002152/PCBB-HN

